121 related articles for article (PubMed ID: 15894692)
41. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
[TBL] [Abstract][Full Text] [Related]
42. Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.
Malagón T; Louvanto K; Ramanakumar AV; Koushik A; Coutlée F; Franco EL;
Gynecol Oncol; 2019 Nov; 155(2):245-253. PubMed ID: 31604665
[TBL] [Abstract][Full Text] [Related]
43. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.
Sundström K; Ploner A; Dahlström LA; Palmgren J; Dillner J; Adami HO; Ylitalo N; Sparén P
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):150-8. PubMed ID: 23155137
[TBL] [Abstract][Full Text] [Related]
44. Role of Human Papillomavirus DNA Load in Predicting the Long-term Risk of Cervical Cancer: A 15-Year Prospective Cohort Study in China.
Zhao X; Zhao S; Hu S; Zhao K; Zhang Q; Zhang X; Pan Q; Zhao F
J Infect Dis; 2019 Jan; 219(2):215-222. PubMed ID: 31067317
[TBL] [Abstract][Full Text] [Related]
45. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species.
Xi LF; Edelstein ZR; Meyers C; Ho J; Cherne SL; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2507-12. PubMed ID: 19690188
[TBL] [Abstract][Full Text] [Related]
47. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
[TBL] [Abstract][Full Text] [Related]
48. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.
Peto J; Gilham C; Deacon J; Taylor C; Evans C; Binns W; Haywood M; Elanko N; Coleman D; Yule R; Desai M
Br J Cancer; 2004 Aug; 91(5):942-53. PubMed ID: 15292939
[TBL] [Abstract][Full Text] [Related]
49. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients.
Nath R; Mant C; Luxton J; Hughes G; Raju KS; Shepherd P; Cason J
Arthritis Rheum; 2007 May; 57(4):619-25. PubMed ID: 17471531
[TBL] [Abstract][Full Text] [Related]
50. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
Jeronimo J; Bansil P; Valdez M; Kang LN; Zhao FH; Qiao YL; Chen W; Zhang X; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
J Low Genit Tract Dis; 2015 Jul; 19(3):220-3. PubMed ID: 25279978
[TBL] [Abstract][Full Text] [Related]
51. Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy.
Carcopino X; Henry M; Mancini J; Giusiano S; Boubli L; Olive D; Tamalet C
J Med Virol; 2012 Feb; 84(2):306-13. PubMed ID: 22170552
[TBL] [Abstract][Full Text] [Related]
52. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
53. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
[TBL] [Abstract][Full Text] [Related]
54. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
55. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
Monsonego J; Cox JT; Behrens C; Sandri M; Franco EL; Yap PS; Huh W
Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973
[TBL] [Abstract][Full Text] [Related]
57. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
Pajtler M; Milicić-Juhas V; Milojković M; Topolovec Z; Curzik D; Mihaljević I
Coll Antropol; 2010 Mar; 34(1):81-6. PubMed ID: 20432737
[TBL] [Abstract][Full Text] [Related]
58. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
[TBL] [Abstract][Full Text] [Related]
60. Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort.
Gilham C; Sargent A; Peto J
BJOG; 2020 Jan; 127(1):58-68. PubMed ID: 31541495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
